Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients

Clinical trial NCT02239731 · COMPLETED

Trial details

NCT number: NCT02239731
Sponsor: Vyne Therapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rash Due to Epidermal Growth Factor Receptor Inhibitors

Start date: 2014-10-01
Primary completion: 2015-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.